Trump's Generic Drug Tariff Plan Threatens India's Pharma Exports to US

US President Donald Trump has proposed new tariffs on generic drugs, with rates potentially ranging from 0% to 200%. India, widely regarded as the world's pharmacy, is a major supplier of generic medicines globally. Indian generics account for nearly 40% of the US market by volume, making the country significantly exposed to any new trade measures. The proposed tariffs could have a substantial impact on India's pharmaceutical export industry if implemented.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in